UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR
15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 1999
[ ] TRANSITION REPORT PURSUANT TO SECTION 12 OR
15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ____ TO ____.
COMMISSION FILE NUMBER:
333-12929
WEIDER NUTRITION INTERNATIONAL, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 87-0563574
(STATE OR OTHER JURISDICTION (I.R.S. EMPLOYER
OF INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
2002 SOUTH 5070 WEST
SALT LAKE CITY, UTAH 84104-4726
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
Registrant's telephone number, including area code:
(801) 975-5000
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [X] No [ ]
The number of shares outstanding of the Registrant's common stock is 25,042,073
(as of November 30, 1999.)
<PAGE>
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
<TABLE>
<CAPTION>
NOVEMBER 30, MAY 31,
ASSETS 1999 1999
--------- ---------
(UNAUDITED)
<S> <C> <C>
Current assets:
Cash and cash equivalents ............................... $ 2,805 $ 1,926
Receivables ............................................. 51,559 60,524
Inventories ............................................. 55,876 63,658
Prepaid expenses and other .............................. 3,472 4,712
Deferred taxes .......................................... 5,400 7,387
--------- ---------
Total current assets ................................ 119,112 138,207
--------- ---------
Property and equipment, net ............................... 49,297 48,872
--------- ---------
Other assets:
Intangible assets, net .................................. 52,588 51,980
Deposits and other assets ............................... 10,633 12,806
Notes receivable related to
stock performance units ............................... 4,147 4,164
--------- ---------
Total other assets .................................. 67,368 68,950
--------- ---------
Total assets .................................. $ 235,777 $ 256,029
========= =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable ........................................ $ 19,239 $ 25,492
Accrued expenses ........................................ 19,493 18,406
Earnout amounts payable ................................. 929 3,246
Current portion of long-term debt(Note 2) ............... 99,675 110,716
--------- ---------
Total current liabilities ........................... 139,336 157,860
--------- ---------
Long-term debt ............................................ 4,077 4,723
--------- ---------
Deferred taxes ............................................ 824 1,666
--------- ---------
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $.01 per share; shares
authorized-10,000,000; no shares issued and outstanding -- --
Class A common stock, par value $.01 per share; shares
authorized-50,000,000; shares issued and
outstanding-9,354,641 and 9,334,036 ................... 93 93
Class B common stock, par value $.01 per share; shares
authorized-25,000,000; shares issued and
outstanding-15,687,432 ................................ 157 157
Additional paid-in capital .............................. 83,198 82,985
Other accumulated comprehensive loss .................... (2,195) (2,331)
Retained earnings ....................................... 10,287 10,876
--------- ---------
Total stockholders' equity .......................... 91,540 91,780
--------- ---------
Total liabilities and stockholders' equity .... $ 235,777 $ 256,029
========= =========
</TABLE>
See notes to condensed consolidated financial statements.
2
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
(UNAUDITED)
THREE MONTHS ENDED
NOVEMBER 30,
----------------------------
1999 1998
------------ ------------
Net sales ................................. $ 87,376 $ 83,274
Cost of goods sold ........................ 54,515 54,771
------------ ------------
Gross profit .............................. 32,861 28,503
------------ ------------
Operating expenses:
Selling and marketing ................... 18,038 19,267
General and administrative .............. 7,554 6,970
Research and development ................ 1,180 1,419
Amortization of intangible assets ....... 843 809
Plant consolidation and transition ...... -- 4,034
Severance, recruiting and
reorganization costs .................. 851 2,500
------------ ------------
Total operating expenses ............ 28,466 34,999
------------ ------------
Income (loss) from operations ............. 4,395 (6,496)
------------ ------------
Other income (expense):
Interest income ......................... 121 145
Interest expense ........................ (2,758) (2,618)
Other ................................... (53) (211)
------------ ------------
Total other expense, net ............ (2,690) (2,684)
------------ ------------
Income (loss) before income taxes (benefit) 1,705 (9,180)
Provision for income taxes (benefit) ...... 662 (3,740)
------------ ------------
Net income (loss) ......................... $ 1,043 $ (5,440)
============ ============
Weighted average shares outstanding:
Basic ................................... 25,042,073 24,948,381
============ ============
Diluted ................................. 25,047,282 24,948,381
============ ============
Net income (loss) per share:
Basic ................................... $ 0.04 $ (0.22)
============ ============
Diluted ................................. $ 0.04 $ (0.22)
============ ============
Comprehensive income (loss) ............... $ 838 $ (4,540)
============ ============
See notes to condensed consolidated financial statements.
3
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
(UNAUDITED)
SIX MONTHS ENDED
NOVEMBER 30,
----------------------------
1999 1998
------------ ------------
Net sales ................................. $ 177,343 $ 151,220
Cost of goods sold ........................ 110,947 99,189
------------ ------------
Gross profit .............................. 66,396 52,031
------------ ------------
Operating expenses:
Selling and marketing ................... 37,445 31,618
General and administrative .............. 15,069 12,137
Research and development ................ 2,106 2,266
Amortization of intangible assets ....... 1,721 1,433
Plant consolidation and transition ...... -- 4,034
Severance, recruiting and
reorganization costs .................. 2,701 2,500
------------ ------------
Total operating expenses ............ 59,042 53,988
------------ ------------
Income (loss) from operations ............. 7,354 (1,957)
------------ ------------
Other income (expense):
Interest income ......................... 284 302
Interest expense ........................ (5,638) (4,313)
Other ................................... (68) (389)
------------ ------------
Total other expense, net ............ (5,422) (4,400)
------------ ------------
Income (loss) before income taxes (benefit) 1,932 (6,357)
Provision for income taxes (benefit) ...... 643 (2,624)
------------ ------------
Net income (loss) ......................... $ 1,289 $ (3,733)
============ ============
Weighted average shares outstanding:
Basic ................................... 25,037,505 24,869,530
============ ============
Diluted ................................. 25,045,745 24,869,530
============ ============
Net income (loss) per share:
Basic ................................... $ 0.05 $ (0.15)
============ ============
Diluted ................................. $ 0.05 $ (0.15)
============ ============
Comprehensive income (loss) ............... $ 1,425 $ (3,270)
============ ============
See notes to condensed consolidated financial statements.
4
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLARS IN THOUSANDS)
(UNAUDITED)
SIX MONTHS ENDED
NOVEMBER 30,
--------------------
1999 1998
-------- --------
Cash flows from operating activities:
Net income (loss) ................................. $ 1,289 $ (3,733)
Adjustments to reconcile net income (loss) to net
cash provided by (used in) operating activities:
Provision for bad debts ....................... 1,030 660
Deferred taxes ................................ 1,145 269
Depreciation, amortization and asset impairment 5,632 7,559
Management and employee stock
compensation charges ........................ 201 --
Loss on disposition of equipment .............. 4 65
Changes in operating assets and liabilities-
net of assets acquired:
Receivables ................................... 9,519 3,977
Inventories ................................... 8,920 (11,585)
Prepaid expenses and other .................... 1,256 (583)
Deposits and other assets ..................... 1,540 2,599
Accounts payable .............................. (10,086) (656)
Accrued expenses .............................. (1,630) (5,086)
-------- --------
Net cash provided by (used in)
operating activities ...................... 18,820 (6,514)
-------- --------
Cash flows from investing activities:
Acquisition, net of cash acquired ................. (1,164) (24,668)
Purchase of property and equipment ................ (2,697) (6,443)
Purchase of intangibles ........................... (135) --
Proceeds from disposition of equipment ............ 7 1,364
Change in notes receivable ........................ 17 10
Investment in securities available for sale ....... -- (4,998)
-------- --------
Net cash used in investing activities ....... (3,972) (34,735)
-------- --------
Cash flows from financing activities:
Issuance of common stock .......................... 12 139
Dividends paid .................................... (1,878) (1,860)
Proceeds from debt ................................ 1,827 46,135
Payments on debt .................................. (13,989) (1,073)
-------- --------
Net cash provided by (used in)
financing activities ....................... (14,028) 43,341
-------- --------
Effect of exchange rate changes on cash ............. 59 (779)
-------- --------
Increase in cash and cash equivalents ............... 879 1,313
Cash and cash equivalents, beginning of period ...... 1,926 684
-------- --------
Cash and cash equivalents, end of period ............ $ 2,805 $ 1,997
======== ========
See notes to condensed consolidated financial statements.
5
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(DOLLARS IN THOUSANDS)
(UNAUDITED)
1. BASIS OF PRESENTATION AND OTHER MATTERS
The accompanying unaudited interim consolidated financial statements
("interim financial statements") do not include all disclosures provided in the
annual consolidated financial statements. These interim financial statements
should be read in conjunction with the consolidated financial statements and the
footnotes thereto contained in the Weider Nutrition International, Inc. (the
"Company") Annual Report on Form 10-K for the fiscal year ended May 31, 1999 as
filed with the Securities and Exchange Commission. The May 31, 1999 consolidated
balance sheet was derived from audited financial statements, but all disclosures
required by generally accepted accounting principles are not provided in the
accompanying footnotes. The Company is a majority-owned subsidiary of Weider
Health and Fitness ("WHF").
In the opinion of the Company, the accompanying interim financial
statements contain all adjustments (which are of a normal recurring nature)
necessary for a fair presentation of the Company's financial position and
results of operations. Certain prior period amounts have been reclassified to
conform with the current interim period presentation.
2. CREDIT FACILITY
The Company's credit facility with certain lending institutions led by
General Electric Capital Corporation ("GECC") matures in February 2000.
Therefore, the amounts outstanding under the credit facility at November 30,
1999 ($85.0 million) are included in current portion of long-term debt.
The Company has commenced discussions with its current lenders and other
banking institutions regarding either a new credit facility or an extension of
its current facility. Management believes that the Company will obtain an
extension of its current facility prior to maturity and that a new credit
facility will be finalized prior to the filing of the Company's Form 10-K for
the year ending May 31, 2000. However, there can be no assurance that an
extension and/or the new facility will be obtained by such dates or on terms
favorable to the Company. Management expects that amounts outstanding under a
new credit facility will be subsequently reclassified as a long-term obligation.
3. RECEIVABLES
Receivables consist of the following:
NOVEMBER 30, MAY 31,
1999 1999
-------- --------
Trade accounts ..................... $ 51,983 $ 59,389
Income taxes ....................... 1,083 2,195
Other .............................. 1,146 1,168
-------- --------
54,212 62,752
Less allowance for doubtful accounts (2,653) (2,228)
-------- --------
Total ........................ $ 51,559 $ 60,524
======== ========
6
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(DOLLARS IN THOUSANDS)
(UNAUDITED)
4. INVENTORIES
Inventories consist of the following:
NOVEMBER 30, MAY 31,
1999 1999
------------ ------------
Raw materials ... $ 16,162 $ 24,364
Work in process . 2,638 3,364
Finished goods .. 37,076 35,930
------------ ------------
Total $ 55,876 $ 63,658
============ ============
Inventory totaling approximately $4.0 million, primarily consisting of two
raw materials, is included as a long-term asset in deposits and other assets in
the accompanying balance sheets.
5. INTANGIBLE ASSETS
Intangible assets consist of the following:
NOVEMBER 30, MAY 31,
1999 1999
------------ ------------
Cost in excess of fair value
of net assets acquired (goodwill) $ 55,331 $ 53,706
Patents and trademarks ............ 11,185 10,452
Noncompete agreements ............. 209 209
------------ ------------
66,725 64,367
Less accumulated amortization ..... (14,137) (12,387)
------------ ------------
Total ................. $ 52,588 $ 51,980
============ ============
6. OPERATING SEGMENTS
In fiscal 1999, the Company adopted SFAS No. 131, "Disclosures About
Segments of an Enterprise and Related Information", which changes the way the
Company reports information about its operating segments.
The Company has two primary reportable segments. These segments include
the Company's U.S. based or domestic operations and the Company's international
operations. The Company has three primary areas within its domestic operations:
mass market; health food stores; and health clubs and gyms. The Company
manufactures and markets nutritional products, including a broad line of
vitamins, joint-related and other nutraceuticals, and sports nutrition
supplements in mass market; a broad line of vitamins, nutraceuticals and sports
nutrition products primarily through independent distributors and a significant
retailer in health food stores; and a broad line of sports nutrition products
primarily through distributors in health clubs and gyms. The Company also
manufactures and markets nutritional and other products, including a broad line
of sports nutrition supplements and sportswear, together with certain other
nutraceuticals in its international operations.
7
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(DOLLARS IN THOUSANDS)
(UNAUDITED)
The accounting policies of these segments are the same as those described
in Note 1 to the consolidated financial statements (See the Company's Annual
Report on Form 10-K). The Company evaluates the performance of its operating
segments based on actual and expected operating results of the respective
segments. Certain noncash and other expenses, and domestic assets, are not
allocated to the areas within the domestic operating segment.
Segment information for the six months ended November 30, 1999 and 1998,
respectively, are summarized as follows:
INCOME
(LOSS)
NET FROM INTEREST
1999: SALES OPERATIONS EXPENSE
--------- ---------- ---------
Domestic Operations:
Mass market .......... $ 85,814 $ 9,390 $ 1,725
Health food stores ... 21,177 (588) 965
Health clubs and gyms 10,500 (270) 621
Other ................ 2,548 (697) 137
Unallocated .......... -- (2,701) --
--------- ---------- ---------
120,039 5,134 3,448
International Operations 57,304 2,220 2,190
--------- ---------- ---------
$ 177,343 $ 7,354 $ 5,638
========= ========== =========
INCOME
(LOSS)
NET FROM INTEREST
1998: SALES OPERATIONS EXPENSE
--------- ---------- ---------
Domestic Operations:
Mass market .......... $ 68,460 $ 5,429 $ 1,550
Health food stores ... 29,336 (329) 721
Health clubs and gyms 11,616 (146) 369
Other ................ 8,564 (1,578) 136
Unallocated .......... -- (6,534) --
--------- ---------- ---------
117,976 (3,158) 2,776
International Operations 33,244 1,201 1,537
--------- ---------- ---------
$ 151,220 $ (1,957) $ 4,313
========= ========== =========
Reconciliation of total assets for the reportable segments is as follows
at November 30, 1999:
Total domestic assets $ 208,755
Total international assets 81,729
Eliminations (54,707)
---------
Total $ 235,777
=========
8
<PAGE>
WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
Capital expenditures for domestic and international operations amounted to
$1.8 million and $.9 million, respectively, for the six months ended November
30, 1999, and $5.9 million and $0.5 million, respectively, for the six months
ended November 30, 1998. The majority of international related long-lived assets
are located in Germany.
7. SALES TO MAJOR CUSTOMERS
The Company's three largest customers accounted for approximately 44% and
42%, respectively, of net sales for the six months ended November 30, 1999 and
1998, respectively. At November 30, 1999 and May 31, 1999, amounts due from
these customers represented approximately 41% and 42%, respectively, of total
trade accounts receivable.
8. CONTINGENCIES
In March 1999, the plaintiff's attorney involved in a previously settled
California matter regarding certain of the Company's bar products filed a
lawsuit on behalf of Michael Morelli and an alleged class in the Supreme Court
of the State of New York (New York County) alleging similar unfair competition
and false claims under New York law. In May 1999, the plaintiffs' attorney also
filed a lawsuit on behalf of Lisa Fasig and an alleged class in the Circuit
Court of Lee County, Florida alleging similar claims under Florida law. The
Company disputes the allegations and is vigorously opposing the lawsuits.
After discussions and negotiations between the Company and the Federal
Trade Commission (the "FTC"), the Company accepted, without admitting liability,
a proposed consent decree in June 1999 which provided, among other things, that
the Company will not make certain diet and weight loss claims for its products
without adequate scientific substantiation. In November 1999, the FTC
Commissioners did not approve the final consent decree. Accordingly, the Company
and the FTC are continuing discussions regarding this matter. The Company is
unable to predict whether it will be able to reach a negotiated settlement of
this matter. No assurance can be given that any imposition of injunctive relief
and/or penalties in resolving this matter would not have a material adverse
effect on the Company.
The Company is involved in other claims, legal actions and governmental
proceedings that arise from the Company business operations. Although ultimate
liability cannot be determined at the present time, the Company believes that
any liability resulting from these matters, if any, after taking into
consideration the Company's insurance coverage, will not have a material adverse
effect on the Company's financial position or cash flows.
9
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
THE FOLLOWING DISCUSSION AND ANALYSIS SHOULD BE READ IN CONJUNCTION WITH
THE CONSOLIDATED FINANCIAL STATEMENTS, INCLUDING THE NOTES THERETO, APPEARING
ELSEWHERE IN THIS QUARTERLY REPORT ON FORM 10-Q. EXCEPT FOR THE HISTORICAL
INFORMATION CONTAINED HEREIN, THE MATTERS DISCUSSED IN THIS QUARTERLY REPORT
CONTAIN FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE
SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED, THAT ARE BASED ON MANAGEMENT'S BELIEFS AND ASSUMPTIONS,
CURRENT EXPECTATIONS, ESTIMATES, AND PROJECTIONS. STATEMENTS THAT ARE NOT
HISTORICAL FACTS, INCLUDING WITHOUT LIMITATION STATEMENTS WHICH ARE PRECEDED BY,
FOLLOWED BY OR INCLUDE THE WORDS "BELIEVES," "ANTICIPATES," "PLANS," "EXPECTS,"
"MAY," "SHOULD" OR SIMILAR EXPRESSIONS ARE FORWARD-LOOKING STATEMENTS. THESE
STATEMENTS ARE SUBJECT TO RISKS AND UNCERTAINTIES, CERTAIN OF WHICH ARE BEYOND
THE COMPANY'S ABILITY TO PREDICT OR CONTROL, AND, THEREFORE, ACTUAL RESULTS MAY
DIFFER MATERIALLY. THE COMPANY DISCLAIMS ANY OBLIGATION TO UPDATE ANY
FORWARD-LOOKING STATEMENTS WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS
OR OTHERWISE.
IMPORTANT FACTORS THAT MAY EFFECT FUTURE RESULTS INCLUDE, BUT ARE NOT
LIMITED TO: COMPLETION OF THE SKU REDUCTION PROGRAM AS ANTICIPATED BY THE
COMPANY, THE COMPANY'S ABILITY TO IMPLEMENT MORE SOPHISTICATED OPERATING SYSTEMS
AND INVENTORY MANAGEMENT PROGRAMS, THE IMPACT OF COMPETITIVE PRODUCTS AND
PRICING, THE IMPACT OF NEW FDA DIETARY SUPPLEMENT REGULATIONS PUBLISHED ON
JANUARY 6, 2000 ON THE COMPANY'S PRODUCTS AND MARKETING PLANS, INCLUDING,
WITHOUT LIMITATION, PRODUCT LABELING, PRODUCT NAMES AND PRODUCT
STRUCTURE/FUNCTION CLAIMS, DEPENDENCE ON INDIVIDUAL PRODUCTS, THE REALIZABLE
VALUE OF DISCONTINUED SKUS, MARKET CONDITIONS INCLUDING PRICING, DEMAND FOR
PRODUCTS, AND THE LEVEL OF TRADE INVENTORIES, THE SUCCESS OF PRODUCT DEVELOPMENT
AND NEW PRODUCT INTRODUCTIONS INTO THE MARKETPLACE, CHANGES IN LAWS AND
REGULATIONS, THE COMPANY'S ABILITY TO IDENTIFY, RECRUIT AND INTEGRATE KEY
MANAGEMENT PERSONNEL, INCLUDING THE COST AND TIMING THEREOF, LITIGATION AND
GOVERNMENT REGULATORY ACTION, AVAILABILITY OF FUTURE FINANCING, UNCERTAINTY OF
MARKET ACCEPTANCE OF NEW PRODUCTS, RESULTS OF MANAGEMENT'S EVALUATION OF ITS
BUSINESS OPERATIONS AND STRATEGIES, AND OTHER RISKS INDICATED FROM TIME TO TIME
IN THE COMPANY'S SEC REPORTS, COPIES OF WHICH ARE AVAILABLE UPON REQUEST FROM
THE COMPANY'S INVESTOR RELATIONS DEPARTMENT.
GENERAL
Weider Nutrition International, Inc. (the "Company") develops,
manufactures, markets, distributes and sells branded and private label vitamins,
nutritional supplements and sports nutrition products in the United States and
throughout the world. The Company offers a broad range of capsules and tablets,
powdered drink mixes, bottled beverages and nutrition bars, consisting of
approximately 850 nutritional supplement stock keeping units ("SKUs")
domestically and internationally. The Company has a portfolio of recognized
brands, including Schiff(R), Weider Sports Nutrition, MetaForm(R), American Body
Building(TM), Multipower(R), Multaben(R) and Venice Beach(R) that are primarily
marketed through mass market, health food store and/or health club and gym
distribution channels. The Company markets its branded nutritional supplement
products in four principal categories: sports nutrition; vitamins, minerals and
herbs; weight management; and healthy snacks. As a result of the Company's July
1998 acquisition of Haleko Hanseatisches Lebensmittel Kontor GmbH ("Haleko"),
the Company has significantly expanded its operations outside the United States.
The Company's international operations include sports nutrition supplements,
other nutraceuticals and sportswear products.
10
<PAGE>
On January 6, 2000, the FDA published new regulations governing labeling
and structure/function claims for dietary supplements. The Company is evaluating
the new regulations, but has not yet determined the impact, if any, of the new
regulations on the Company's products and results of operations. Accordingly, no
assurance can be given that compliance with the new regulations will not have a
material adverse effect on the Company's results of operations and financial
condition.
The Company's principal executive offices are located at 2002 South 5070
West, Salt Lake City, Utah 84104 and its telephone number is (801) 975-5000. As
used herein, the "Company" means Weider Nutrition International, Inc. and its
subsidiaries, except where indicated otherwise.
RESULTS OF OPERATIONS (UNAUDITED)
THREE MONTHS ENDED NOVEMBER 30, 1999 COMPARED TO THREE MONTHS ENDED
NOVEMBER 30, 1998
The following table shows selected items expressed on an actual basis and
as a percentage of net sales for the respective interim periods:
THREE MONTHS ENDED NOVEMBER 30,
------------------------------------------
1999 1998
------------------- -------------------
(DOLLARS IN THOUSANDS)
Net sales ...................... $ 87,376 100.0% $ 83,274 100.0%
Cost of goods sold ............. 54,515 62.4 54,771 65.8
-------- -------- -------- -------
Gross profit ................... 32,861 37.6 28,503 34.2
-------- -------- -------- -------
Operating expenses ............. 27,615 31.6 28,465 34.2
Plant consolidation
and transition ............... -- -- 4,034 4.8
Severance, recruiting and
reorganization costs ......... 851 1.0 2,500 3.0
-------- -------- -------- -------
Total operating expenses ....... 28,466 32.6 34,999 42.0
-------- -------- -------- -------
Income (loss) from operations .. 4,395 5.0 (6,496) (7.8)
Other expense, net ............. 2,690 3.1 2,684 3.2
Income taxes (benefit) ......... 662 0.7 (3,740) (4.5)
-------- -------- -------- -------
Net income (loss) .............. $ 1,043 1.2% $ (5,440) (6.5)%
======== ======== ======== =======
NET SALES. Net sales for the three months ended November 30, 1999
increased $4.1 million, or 4.9%, to $87.4 million from $83.3 million for the
three months ended November 30, 1998. Sales to mass market retailers (including
food, drug, mass, club and convenience stores) and international markets
increased during the three months ended November 30, 1999 compared to the three
months ended November 30, 1998. Sales to health food distributors and retailers,
health club and gym distributors and contract manufacturing sales decreased
during the second quarter of fiscal 2000 compared to the second quarter of
fiscal 1999.
Second quarter fiscal 2000 sales to mass market retailers increased
approximately 11.7% to $40.1 million from second quarter fiscal 1999 sales of
$35.9 million. The increase in sales to mass market retailers was primarily the
result of increased sales of Pain Free(TM) to existing accounts offset by
reduced volumes of certain other branded products primarily due to the Company's
SKU reduction program and a temporary delay in the introduction of new products.
Sales of Pain Free(TM) amounted to $21.8 million for the second quarter of
fiscal 2000 compared to $13.2 million for the second quarter of fiscal 1999.
Sales to health food distributors and retailers decreased approximately 34.4% to
$10.4 million for the fiscal 2000 second quarter from
11
<PAGE>
$15.9 million for the fiscal 1999 second quarter. Sales to health club and gym
distributors decreased approximately 19.5% to $4.7 million for the second
quarter of fiscal 2000 from $5.8 million for the second quarter of fiscal 1999.
The decrease in sales resulted primarily from the Company's increased focus on
the mass market distribution channel, as well as a temporary delay in the
introduction of new products into the health food, and health club and gym
distribution channels. The Company intends to launch new products, including
line extensions, into its primary distribution channels selectively during the
Company's fiscal 2000 third and fourth quarters.
Sales to international markets increased 39.0% to $31.0 million for the
three months ended November 30, 1999 compared to $22.3 million for the three
months ended November 30, 1998. The increased sales volume is due primarily to
sportswear sales growth in the Company's European operations.
Contract manufacturing (private label) sales volume decreased
approximately 95.0% to $.1 million for the second quarter of fiscal 2000 from
$2.5 million for the second quarter of fiscal 1999. The decrease in contract
manufacturing sales is consistent with the Company's decision to limit contract
manufacturing business to only those customers who have, or may in the future
have, other business relationships with the Company. Private label business for
customers with whom other business relationships exist are included in the net
sales amounts for the distribution channel applicable to the customer.
GROSS PROFIT. Gross profit increased approximately 15.3% to $32.9 million
for the quarter ended November 30, 1999 compared to $28.5 million for the
quarter ended November 30, 1998. Gross profit, as a percentage of net sales, was
37.6% for the quarter ended November 30, 1999 compared to 34.2% for the quarter
ended November 30, 1998. The increase in the gross profit percentage resulted
primarily from consolidation of the Company's capsule and tablet manufacturing
facilities, change in sales mix, reduced credits for returned products and
decreased inventory related costs.
OPERATING EXPENSES. Operating expenses, including certain severance,
recruiting and reorganization costs, decreased approximately 18.7% to $28.5
million for the fiscal 2000 second quarter from $35.0 million for the fiscal
1999 second quarter. During the fiscal 2000 second quarter the Company continued
its organizational changes and upgrading of management systems (including senior
management changes) that resulted in approximately $0.9 million of costs during
the three month period. During the fiscal 1999 second quarter the Company
recognized, in aggregate, approximately $6.5 million in charges relating to the
consolidation of capsule and tablet manufacturing to its Utah facility as well
as severance costs related to the departure of a former CEO and the termination
of approximately twenty employees. Excluding these charges for the respective
periods, operating expenses decreased $0.9 million, or 3.0% during the second
quarter of fiscal 2000 in comparison to the second quarter of fiscal 1999.
Selling and marketing expenses, including sales, marketing, adver- tising,
freight and other costs, decreased approximately 6.4% to $18.0 million for the
fiscal 2000 second quarter from $19.3 million for the fiscal 1999 second
quarter. The decrease in selling and marketing expenses resulted primarily from
a decrease in sales subject to royalties and other direct selling expenses as
well as a reduction in certain promotional costs. The Company expects its
selling and marketing expenses, as a percentage of sales, to increase during the
third and fourth quarters of fiscal 2000.
12
<PAGE>
General and administrative expenses increased approximately 8.4% to $7.6
million for the quarter ended November 30, 1999 compared to $7.0 million for the
quarter ended November 30, 1998. The increase in general and administrative
expenses for the second quarter of fiscal 2000 resulted primarily from
incremental personnel related bonuses and other expenses.
OTHER EXPENSE. Other expense, net, remained constant at $2.7 million for
the quarters ended November 30, 1999 and 1998.
PROVISION FOR INCOME TAXES. Provision for income taxes amounted to $0.7
million for the quarter ended November 30, 1999 compared to a tax benefit of
$3.7 million for the quarter ended November 30, 1998. The increase resulted
primarily from realization of pre-tax earnings for the fiscal 2000 second
quarter in comparison to a pre-tax loss for the fiscal 1999 second quarter.
Effective tax rate changes result primarily from tax rate differences for the
Company's domestic and international operations.
SIX MONTHS ENDED NOVEMBER 30, 1999 COMPARED TO SIX MONTHS ENDED
NOVEMBER 30, 1998
NET SALES. Net sales for the six months ended November 30, 1999
increased $26.1 million, or 17.3%, to $177.3 million from $151.2 million for the
six months ended November 30, 1998. Sales to mass market retailers (including
food, drug, mass, club and convenience stores) and international markets
increased during the six months ended November 30, 1999 compared to the six
months ended November 30, 1998. Sales to health food distributors and retailers,
health club and gym distributors, and contract manufacturing sales decreased
during the first six months of fiscal 2000 compared to the first six months of
fiscal 1999.
Sales to mass volume retailers increased approximately 25.3% to $85.8
million for the six months ended November 30, 1999 from $68.5 million for the
six months ended November 30, 1998. The increase in sales to mass market
retailers was primarily the result of increased sales to existing accounts of
certain leading branded products, offset by reduced volumes of certain other
branded products primarily due to the Company's SKU reduction program and a
temporary delay in the introduction of new products. Sales of Pain Free(TM)
amounted to $48.1 million for the first six months of fiscal 2000 compared to
$28.2 million for the first six months of fiscal 1999. Sales to health food
distributors and retailers decreased approximately 27.8% to $21.2 million for
the first six months of fiscal 2000 from $29.3 million for fiscal 1999. Sales to
health club and gym distributors decreased approximately 9.6% to $10.5 million
from $11.6 million for the six months ended November 30, 1998. The decrease in
sales resulted primarily from the Company's increased focus on the mass market
distribution channel as well as a temporary delay in the introduction of new
products in fiscal 2000 as compared to the first six months of fiscal 1999. The
Company intends to launch new products, including line extensions, into its
primary distribution channels selectively during the Company's fiscal 2000 third
and fourth quarters.
Sales to international markets increased 72.4% to $57.3 million for the
six months ended November 30, 1999 compared to $33.2 million for the six months
ended November 30, 1998. The increase in sales to international markets resulted
primarily from the Company's acquisition of Haleko in July 1998. The Company's
financial results for the first six months of fiscal 2000 included Haleko's
operating results for six months (compared to four months included in the first
six months of fiscal 1999), which consisted of $47.5 million in sales volume.
13
<PAGE>
Contract manufacturing (private label) sales volume decreased
approximately 93.9% to $0.4 million for the first six months of fiscal 2000 from
$6.1 million for the first six months of fiscal 1999. The decrease in contract
manufacturing sales is consistent with the Company's decision to limit contract
manufacturing business to only those customers who have, or may in the future
have, other business relationships with the Company. Private label business for
customers with whom other business relationships exist are included in the net
sales amounts for the distribution channel applicable to the customer.
GROSS PROFIT. Gross profit increased approximately 27.6% to $66.4 million
for the six months ended November 30, 1999 compared to $52.0 million for the six
months ended November 30, 1998. Gross profit, as a percentage of net sales, was
37.4% for the six months ended November 30, 1999 compared to 34.4% for the six
months ended November 30, 1998. The increase in the gross profit percentage
resulted primarily from consolidation of the Company's capsule and tablet
manufacturing facilities, increased higher margin international sales, change in
sales mix and reduced credits for returned products.
OPERATING EXPENSES. Operating expenses, including certain severance,
recruiting and reorganization costs, increased approximately 9.4% to $59.0
million for the first six months of fiscal 2000 from $54.0 million for the first
six months of fiscal 1999. During the first six months of fiscal 2000 the
Company continued its initiative for organizational changes and upgrading of
management systems (including senior management changes) that resulted in
approximately $2.7 million of costs during the six month period. During the
fiscal 1999 second quarter the Company recognized, in aggregate, approximately
$6.5 million in charges relating to the consolidation of capsule and tablet
manufacturing to its Utah facility as well as severance costs related to the
departure of a former CEO and the termination of approximately twenty employees.
Excluding these charges for the respective periods, operating expenses increased
$8.9 million, or 18.7% during the first six months of fiscal 2000 in comparison
to the first six months of fiscal 1999.
Selling and marketing expenses, including sales, marketing, adver- tising,
freight and other costs, increased approximately 18.4% to $37.4 million for the
first six months of fiscal 2000 from $31.6 million for the first six months of
fiscal 1999. The increase in selling and marketing expenses resulted primarily
from the acquisition of Haleko ($3.9 million), increased advertising and
promotion costs associated with the Company's brand building initiative and
personnel costs required to handle higher sales volumes. The Company expects its
selling and marketing expenses, as a percentage of sales, to increase during the
third and fourth quarters of fiscal 2000.
General and administrative expenses increased approximately 24.2% to $15.1
million for the six months ended November 30, 1999 compared to $12.1 million for
the six months ended November 30, 1998. The increase in general and
administrative expenses for the first six months of fiscal 2000 resulted
primarily from the acquisition of Haleko ($2.8 million), additional overhead
costs associated with higher sales volumes and increased employee bonuses and
other personnel costs.
OTHER EXPENSE. Other expense, net, amounted to $5.4 million for the six
months ended November 30, 1999 compared to $4.4 million for the six
14
<PAGE>
months ended November 30, 1998. The net increase of approximately $1.0 million
resulted primarily from increased interest costs associated with additional
indebtedness incurred in connection with the acquisition of Haleko, together
with an overall higher effective borrowing rate.
PROVISION FOR INCOME TAXES. Provision for income taxes amounted to $0.6
million for the six months ended November 30, 1999 compared to a tax benefit of
$2.6 million for the six months ended November 30, 1998. The increase resulted
primarily from realization of pre-tax earnings for the fiscal 2000 second
quarter in comparison to a pre-tax loss for the fiscal 1999 second quarter.
Effective tax rate changes result primarily from tax rate differences for the
Company's domestic and international operations.
LIQUIDITY AND CAPITAL RESOURCES. Concurrent with the Company's IPO,
effective May 1, 1997, the Company entered into an amended credit agreement (the
"Credit Agreement") with certain lending institutions led by GECC. The Credit
Agreement is a $115.0 million senior secured, long-term credit facility that
contains standard terms and conditions, including, subject to permitted amounts,
a limitation on the ability of the Company to pay dividends on the common stock
and minimum net worth requirements. The obligations of the Company under the
Credit Agreement are secured by a first priority lien on all owned or acquired
tangible and intangible assets of the Company and a pledge to GECC of the
capital stock of the U.S. subsidiaries of the Company, including the subsidiary
that owns the Company's foreign subsidiaries. Borrowings available under the
Credit Agreement are used for general working capital, to support capital
expenditures and for other investment considerations. Borrowings under the
Credit Agreement bear interest at floating rates and mature in February 2000
(See Note 2 to the Condensed Consolidated Financial Statements). Accordingly,
amounts outstanding under the Credit Agreement at November 30, 1999, are
included in the current portion of long-term debt. At November 30, 1999, the
Company had approximately $30.0 million of available credit under the Credit
Agreement.
Excluding amounts outstanding under the Credit Agreement($85.0 million),
the Company had working capital of approximately $64.8 million at November 30,
1999 compared to $79.0 million at May 31, 1999. The decrease resulted primarily
from reduced receivables and inventories. Current receivables and inventories
decreased $9.0 million and $7.8 million, respectively, during the six months
ended November 30, 1999. The decrease in receivables was primarily attributable
to a change in customer sales mix. The decrease in inventories was primarily
attributable to improved inventory management, including the Company's SKU
reduction program.
During the first six months of fiscal 2000, the Company's aggregate
current and long-term debt decreased approximately $11.7 million to $103.8
million at November 30, 1999, primarily as a result of the decrease in
receivables and inventories.
The Company expects to fund its long-term capital requirements for the
next twelve months through the use of operating cash flow supplemented as
necessary by borrowings under the Credit Agreement (and/or alternative
financing; see Note 2 to the Condensed Consolidated Financial Statements) and,
if necessary, through debt financing or the issuance of additional equity. The
Company also from time to time may evaluate strategic acquisitions as the
nutritional supplements industry continues to consolidate. The funding of any
future acquisitions, if any, may also require borrowings under the Credit
Agreement, as amended, and/or other debt financing or the issuance of additional
equity.
15
<PAGE>
The Company paid a quarterly dividend of $0.0375 per share subsequent to
November 30, 1999. The dividend was declared to be payable on December 20, 1999
to holders of all classes of common stock of record at the close of business on
December 10, 1999. The Company's Board of Directors will determine dividend
policy in the future based upon, among other things, the Company's results of
operations, financial condition, contractual restrictions and other factors
deemed relevant at the time. In addition, the Credit Agreement contains certain
customary financial covenants that may limit the Company's ability to pay
dividends on its common stock. Accordingly, there can be no assurance that the
Company will be able to sustain the payment of dividends in the future.
IMPACT OF INFLATION. The Company has historically been able to pass
inflationary increases for raw materials and other costs through to its
customers and anticipates that it will be able to continue to do so in the
future.
SEASONALITY. The Company's business has historically been seasonal, with
lower sales typically realized during the first and second fiscal quarters and
higher sales typically realized during the third and fourth fiscal quarters. The
Company believes such fluctuations in sales are the result of greater marketing
and promotional activities toward the end of each fiscal year, customer buying
patterns, and consumer spending patterns related primarily to the consumers'
interest in achieving personal health and fitness goals after the beginning of
each new calendar year and before the summer fashion season.
Furthermore, as a result of changes in product sales mix and other
factors, as discussed above, the Company experiences fluctuations in gross
profit and operating margins on a quarter-to-quarter basis.
YEAR 2000. As of January 14, 2000, the Company is not aware of any
material year 2000 problems in any of its critical systems and services. In
addition, the Company has not received any notification from any supplier of
critical systems or services of any material year 2000 related problems in their
businesses. In the event that any year 2000 related problems arise in the
future, the Company formulated a year 2000 plan to address such issues. However,
although the Company has a year 2000 plan, no assurance can be given that such
plan will be able to solve all year 2000 issues that might still arise or that
the failure to solve any such year 2000 issue will not have a material adverse
effect on the Company.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The information set forth in Note 8 to Condensed Consolidated
Financial Statements in Item 1 of this Quarterly Report on Form 10-Q is
incorporated herein by reference.
ITEM 2. CHANGES IN SECURITIES.
Not applicable.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
Not applicable.
16
<PAGE>
ITEM 4. SUBMISSION OF MATTER TO A VOTE OF SECURITY HOLDERS.
The Company's Annual Meeting of Shareholders was held on November
17, 1999 for the following purposes:
PROPOSAL ONE: Election of the Company's Board of Directors.
- ------------
FOR WITHHELD AUTHORITY
----------- ------------------
Eric Weider 159,812,473 44,702
George Lengvari 159,811,958 45,217
Bruce J. Wood 159,811,073 46,102
Ronald L. Corey 159,830,573 26,602
Donald G. Drapkin 159,830,973 26,202
David J. Gustin 159,811,678 45,497
Roger H. Kimmel 159,811,473 45,702
Glenn W. Schaeffer 159,831,073 26,102
PROPOSAL TWO: Approval of amendments to the Company's 1997 Equity Participation
Plan, as amended(the "Equity Plan"), to (i) increase the number of shares of the
Company's Class A Common Stock available for issuance under the Equity Plan from
2,496,000 to 3,500,000 shares, and (ii) increase the maximum number of shares
which may be subject to options or awards to any individual in fiscal year from
300,000 to 600,000 shares.
FOR AGAINST ABSTAIN/BROKER NON-VOTES
----------- --------- ------------------------
157,681,358 1,761,615 414,202
ITEM 5. OTHER INFORMATION.
Not applicable.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits:
5.1 Stock Purchase Agreement, dated July 9, 1998, by and among Weider
Nutrition Group, Inc. and Wolfgang Brandt and Eberhardt Schluter. (2)
5.2 Amendment Deed to Stock Purchase Agreement, dated July 24, 1998. (2)
5.3 Share Transfer Deed, dated July 24, 1998. (2)
3.1 Amended and Restated Certificate of Incorporation of Weider Nutrition
International, Inc. (1)
3.2 Amended and Restated Bylaws of Weider Nutrition International, Inc. (1)
4.1 Amended and Restated Credit Agreement dated as of May 6, 1997 among Weider
Nutrition International, Inc., certain subsidiaries, certain lenders and
General Electric Capital Corporation. (3)
4.2 First Amendment to Amended and Restated Credit Agreement dated as of
August 27, 1997 among Weider Nutrition International, Inc. and certain of
its affiliates and General Electric Capital Corporation and certain other
lenders. (3)
4.3 Second Amendment to Amended and Restated Credit Agreement dated as of
February 1998 among Weider Nutrition International, Inc. and certain of
its affiliates and General Electric Capital Corporation and certain other
lenders. (3)
4.4 Third Amendment to Amended and Restated Credit Agreement dated as of
July 28, 1998 among Weider Nutrition International, Inc. and certain of
its affiliates and General Electric Capital Corporation and certain other
lenders. (4)
4.5 Fourth Amendment to Amended and Restated Credit Agreement dated as of
December 2, 1998 among Weider Nutrition International, Inc. and certain of
its affiliates and General Electric Capital Corporation and certain other
lenders. (4)
17
<PAGE>
4.6 Fifth Amendment to Amended and Restated Credit Agreement dated as of
December 15, 1998 among Weider Nutrition International, Inc. and certain
of its affiliates and General Electric Capital Corporation and certain
other lenders. (4)
4.7 Sixth Amendment to Amended and Restated Credit Agreement dated as of
March 4, 1999 among Weider Nutrition International, Inc. and certain of
its affiliates and General Electric Capital Corporation and certain other
lenders. (5)
4.8 Seventh Amendment to Amended and Restated Credit Agreement dated as of
June 24, 1999 among Weider Nutrition International, Inc. and certain of
its affiliates and General Electric Capital Corporation and certain other
lenders. (6)
4.9 Haleko Credit Agreement dated as of July 22, 1999, among Haleko and
certain other lenders. (7)
10.1 Build-To-Suit Lease Agreement, dated March 20, 1996, between SCI
Development Services Incorporated and Weider Nutrition Group, Inc. (1)
10.2 Agreement by and between Joseph Weider and Weider Health and Fitness. (1)
10.3 1997 Equity Participation Plan of Weider Nutrition International, Inc. (1)
10.4 Form of Tax Sharing Agreement by and among Weider Nutrition International,
Inc. and its subsidiaries and Weider Health and Fitness and its
subsidiaries. (1)
10.5 Form of employment Agreement between Weider Nutrition International, Inc.
and Richard B. Bizzaro. (1)
10.6 Form of Employment Agreement between Weider Nutrition International, Inc.
and Robert K. Reynolds, as amended. (5)
10.7 Form of Senior Executive Employment Agreement between Weider Nutrition
International, Inc. and certain senior executives of the Company. (1)
10.8 Advertising Agreement between Weider Nutrition International, Inc. and
Weider Publications, Inc. (1)
10.9 Amended and Restated Shareholders Agreement between Weider Health and
Fitness and Hornchurch Investments Limited. (1)
10.10 Amended and Restated Shareholders Agreement between Weider Health and
Fitness, Bayonne Settlement and Ronald Corey. (1)
10.11 Indemnification Agreement between Weider Nutrition Group, Inc. and Showa
Denko America. (1)
10.12 License Agreement between Mariz Gestao E Investmentos Limitada and Weider
Nutrition Group Limited. (1)
10.13 Form of Employment Agreement between Weider Nutrition International, Inc.
and Bruce J. Wood. (6)
10.14 Separation Agreement between Weider Nutrition International, Inc. and
Robert K. Reynolds. (7)
21 Subsidiaries of Weider Nutrition International, Inc. (1)
27.1 FINANCIAL DATA SCHEDULE SUMMARY (8)
- ----------------------------------------
(1) Filed as an Exhibit to the Company's Registration Statement on Form S-1
(File No. 333-12929) and incorporated herein by reference.
(2) Previously filed in the Company's Current Report on Form 8-K dated as of
July 24, 1998 and incorporated herein by reference.
(3) Previously filed in the Company's Current Report on Form 10-Q dated as of
October 14, 1998 and incorporated herein by reference.
(4) Previously filed in the Company's Current Report on Form 10-Q dated as of
January 14, 1999 and incorporated herein by reference.
(5) Previously filed in the Company's Current Report on Form 10-Q dated as of
April 6, 1999 and incorporated herein by reference.
(6) Previously filed in the Company's Current Report on Form 10-K dated as of
August 30, 1999 and incorporated herein by reference.
(7) Previously filed in the Company's Current Report on Form 10-Q dated as of
October 15, 1999.
(8) FILED HEREWITH
(b) Reports on Form 8-K
None
18
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
WEIDER NUTRITION INTERNATIONAL, INC.
Date: January 14, 2000 BY: /s/ BRUCE J. WOOD
----------------------------------
Bruce J. Wood
President, Chief Executive Officer
and Director
Date: January 14, 2000 BY: /s/ JOSEPH W. BATY
----------------------------------
Joseph W. Baty
Senior Vice President and
Chief Accounting Officer
19
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF WEIDER NUTRITION INTERNATIONAL, INC. AS OF,
AND FOR THE SIX MONTHS ENDING NOVEMBER 30 1999, AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAY-31-2000
<PERIOD-END> NOV-30-1999
<CASH> 2,805
<SECURITIES> 2,308
<RECEIVABLES> 54,212
<ALLOWANCES> 2,653
<INVENTORY> 55,876
<CURRENT-ASSETS> 119,112
<PP&E> 69,882
<DEPRECIATION> 20,585
<TOTAL-ASSETS> 235,777
<CURRENT-LIABILITIES> 139,336
<BONDS> 4,077
0
0
<COMMON> 250
<OTHER-SE> 91,290
<TOTAL-LIABILITY-AND-EQUITY> 235,777
<SALES> 177,343
<TOTAL-REVENUES> 177,343
<CGS> 110,947
<TOTAL-COSTS> 110,947
<OTHER-EXPENSES> 59,042
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 5,638
<INCOME-PRETAX> 1,932
<INCOME-TAX> 643
<INCOME-CONTINUING> 1,289
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,289
<EPS-BASIC> .05
<EPS-DILUTED> .05
</TABLE>
